Accretive Health, Inc. (AH)
-NYSE 11.08 
0.21(1.93%) May 17, 4:01PM EDT
| Prev Close: | 10.87 |
|---|
| Open: | 10.90 |
|---|
| Bid: | 7.91 x 100 |
|---|
| Ask: | 11.29 x 300 |
|---|
| 1y Target Est: | 13.67 |
|---|
| Beta: | 0.93 |
|---|
| Next Earnings Date: | 27-May-13 |
|---|
| Day's Range: | 10.90 - 11.18 |
|---|
| 52wk Range: | 8.55 - 14.19 |
|---|
| Volume: | 260,786 |
|---|
| Avg Vol (3m): | 859,203 |
|---|
| Market Cap: | 1.09B |
|---|
| P/E (ttm): | 65.18 |
|---|
| EPS (ttm): | 0.17 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- 5 Stocks Set to Soar on Bullish Earningsat TheStreet(Mon, May 13)
- Law Office of Brodsky & Smith, LLC Announces Investigation of Accretive Healthcare, Inc.PR Newswire(Mon, May 6)
- Accretive Health grants Richard Kimball Jr. a non-qualified stock optiontheflyonthewall.com(Tue, Apr 30)
- Accretive Health Reports Inducement Grant under NYSE Rule 303A.08Business Wire(Tue, Apr 30)
- Joseph Flanagan Joins Accretive Health as Chief Operating OfficerBusiness Wire(Tue, Apr 30)
- ATTENTION SHAREHOLDERS: Accretive Healthcare, Inc (AH) Under Investigation by The Young Law Firm For Possible Violations of Federal Securities LawsBusiness Wire(Tue, Apr 30)
- ACCRETIVE HEALTH, INC. Files SEC form 8-K, Change in Directors or Principal OfficersEDGAR Online(Tue, Apr 30)
- Is The Bad News Already Priced In For These 5 Short Squeeze Picks?at Seeking Alpha(Tue, Apr 23)
- ACCRETIVE HEALTH, INC. Files SEC form 8-K, Change in Directors or Principal OfficersEDGAR Online(Fri, Apr 19)
- ACCRETIVE HEALTH, INC. Files SEC form 8-K, Change in Directors or Principal OfficersEDGAR Online(Fri, Apr 5)
- Accretive Health Reports Inducement Grant under NYSE Rule 303A.08Business Wire(Thu, Apr 4)
- Accretive Health, Inc. - Special Callat Seeking Alpha(Tue, Apr 2)
- Accretive Health names former Dell exec as new CEOAP(Tue, Apr 2)
- Accretive Health, Inc. to Discuss Appointment of Stephen Schuckenbrock as President and CEO - Call scheduled for 5:00 pm ET todayCCBN(Tue, Apr 2)
- After-Hours Buzz: TSLA, ZNGA, GPN & Moreat CNBC(Tue, Apr 2)
Key Statistics
| Forward P/E (1 yr): | 23.57 |
|---|
| P/S (ttm): | 1.10 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Dec-12)
: | 0.25 |
|---|
| Quarterly EPS Est
(Dec-12)
: | 0.09 |
|---|
| Mean Recommendation*: | 2.5 |
|---|
| PEG Ratio (5 yr expected): | 1.69 |
|---|
Business Summary
Accretive Health, Inc. provides revenue cycle management services for hospitals and healthcare providers in the United States. It offers integrated revenue cycle management services that help healthcare providers to manage their revenue cycles, wh...
View More